Degenerative Joint Diseases and Neuroinflammation

Area of Science:

• * Rheumatology and immunology
• * Orthopedics and bone biology

Background:

• * Rheumatic and joint diseases, including osteoarthritis and rheumatoid arthritis, are leading causes of global pain and disability, with prevalence increasing due to aging populations and rising obesity rates.
• * These conditions significantly impair daily activities and employment, with osteoarthritis projected to be the fourth leading cause of disability worldwide.
• * Inflammation is increasingly recognized as a key factor in joint and bone damage, contributing to functional deficits.

Purpose of the Study:

• * To review the current understanding of rheumatic and joint diseases, focusing on pathogenesis and contributing factors.
• * To highlight the limitations of existing symptomatic treatments.
• * To advocate for research into novel therapeutic strategies that target osteoarticular structural elements.

Main Methods:

• * Review of current scientific literature on rheumatic diseases, inflammation, and joint pathology.
• * Analysis of the role of cartilage-bone cross-talk and mast cell dysregulation.
• * Evaluation of the efficacy of current treatment modalities.

Main Results:

• * Osteoarthritis and rheumatoid arthritis are major contributors to disability and loss of productivity.
• * Inflammation, cartilage-bone imbalance, and mast cell activation are implicated in disease progression.
• * Current treatments primarily manage symptoms without altering disease trajectory.

Conclusions:

• * Understanding the complex pathogenesis of rheumatic diseases is crucial for developing effective treatments.
• * Targeting osteoarticular structural elements offers a promising avenue for disease modification.
• * Future research should prioritize the development of disease-modifying therapies to delay progression and reduce the need for joint replacement.